BOSTON SCIENTIFIC CORP — Director's Dealing 2013

Mar 1, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2013-02-27

Reporting Person: Phalen Michael P. (EVP & President, MedSurg)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-27	Common Stock	M	6369.0000	$0.0000	Acquired	75536.0000	Direct
2013-02-27	Common Stock	M	3981.0000	$0.0000	Acquired	79517.0000	Direct
2013-02-27	Common Stock	F	1275.0000	$7.3300	Disposed	78242.0000	Direct
2013-02-27	Common Stock	F	2077.0000	$7.3300	Disposed	76165.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-27	Deferred Stock Units	$	M	3981.0000	Disposed		Common Stock (3981.0000)	Direct
2013-02-27	Deferred Stock Units	$	M	6369.0000	Disposed		Common Stock (6369.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2439.0000	Indirect

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F3: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.

F4: Shares of common stock will be issued to the reporting person in three equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.

F5: Reflects multiple DSU awards with independent vesting schedules.

F6: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.